Literature DB >> 16709177

The biological relevance of chemokine-proteoglycan interactions.

A E I Proudfoot1.   

Abstract

Chemokines exert their biological activity through high-affinity interactions with cell-surface receptors, thereby activating specific signalling pathways, and a second low-affinity interaction with proteoglycans. Proteoglycans consist of a protein core, to which GAG (glycosaminoglycan) chains are attached. The GAGs are long, linear, sulphated and highly charged heterogeneous polysaccharides that are expressed throughout the body in different forms depending on the developmental or pathological state of the organ/organism. Mechanistically, the GAG interaction is thought to facilitate the retention of chemokines on cell surfaces, thereby forming a high local concentration required for cell activation. Recently, we demonstrated that certain chemokines require interactions with GAGs for their in vivo function. Additionally we have shown that chemokines oligomerize on immobilized GAGs, and this ability to form higher order oligomers has also been shown to be essential for the activity of certain chemokines in vivo. We believe that interference with the chemokine-GAG interaction provides a novel anti-inflammatory strategy, exemplified by a variant of RANTES (regulated upon activation, normal T-cell expressed and secreted) that has abrogated GAG binding and oligomerization properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709177     DOI: 10.1042/BST0340422

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  52 in total

1.  Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots.

Authors:  Ziv Shulman; Shmuel J Cohen; Ben Roediger; Vyacheslav Kalchenko; Rohit Jain; Valentin Grabovsky; Eugenia Klein; Vera Shinder; Liat Stoler-Barak; Sara W Feigelson; Tsipi Meshel; Susanna M Nurmi; Itamar Goldstein; Olivier Hartley; Carl G Gahmberg; Amos Etzioni; Wolfgang Weninger; Adit Ben-Baruch; Ronen Alon
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

2.  Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.

Authors:  Urska Repnik; Amanda E Starr; Christopher M Overall; Boris Turk
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

Review 3.  Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

Authors:  Luca Vangelista; Massimiliano Secchi; Paolo Lusso
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

Review 4.  Mast cell proteoglycans.

Authors:  Elin Rönnberg; Fabio R Melo; Gunnar Pejler
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

5.  Selective human endothelial cell activation by chemokines as a guide to cell homing.

Authors:  Claire Crola Da Silva; Nathalie Lamerant-Fayel; Maria Paprocka; Michèle Mitterrand; David Gosset; Danuta Dus; Claudine Kieda
Journal:  Immunology       Date:  2008-09-16       Impact factor: 7.397

6.  HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.

Authors:  Maria A De Francesco; Manuela Baronio; Claudio Poiesi
Journal:  J Biol Chem       Date:  2011-04-11       Impact factor: 5.157

7.  Differential expression of matrix metalloproteinases in the serum of patients with mucopolysaccharidoses.

Authors:  Spyros P Batzios; Dimitrios I Zafeiriou; Euthymia Vargiami; George Karakiulakis; Eleni Papakonstantinou
Journal:  JIMD Rep       Date:  2011-09-22

8.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

Authors:  Graeme O'Boyle; Paul Mellor; John A Kirby; Simi Ali
Journal:  FASEB J       Date:  2009-08-10       Impact factor: 5.191

10.  Structure of mouse IP-10, a chemokine.

Authors:  Talat Jabeen; Philip Leonard; Haryati Jamaluddin; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.